RATIONALE: Home respiratory polygraphy (HRP) may be a cost-effective alternative to polysomnography (PSG) for diagnosis and treatment election in patients with high clinical probability of obstructive sleep apnea (OSA), but there is conflicting evidence on its use for a wider spectrum of patients. OBJECTIVES: To determine the efficacy and cost of OSA management (diagnosis and therapeutic decision making) using (1) PSG for all patients (PSG arm); (2) HRP for all patients (HRP arm); and (3) HRP for a subsample of patients with high clinical probability of being treated with continuous positive airway pressure (CPAP) and PSG for the remainder (elective HRP arm). METHODS: Multicentric study of 366 patients with intermediate-high clinical probability of OSA, randomly subjected to HRP and PSG. We explored the diagnostic and therapeutic decision agreements between the PSG and both HRP arms for several HRP cutoff points and calculated costs for equal diagnostic and/or therapeutic decision efficacy. RESULTS: For equal diagnostic and therapeutic decision efficacy, PSG arm costs were 18% higher than HRP arm costs and 20% higher than elective HRP arm costs. HRP arm costs tended to be lower than elective HRP arm costs, and both tended to be lower than PSG arm costs if patient costs were omitted. CONCLUSION: Home respiratory polygraphy is a less costly alternative than polysomnography for the diagnosis and therapeutic decision making for patients with suspected obstructive sleep apnea. We found no advantage in cost terms, however, in using home respiratory polygraphy for all patients or home respiratory polygraphy for the most symptomatic patients and polysomnography for the rest.
RCT Entities:
RATIONALE: Home respiratory polygraphy (HRP) may be a cost-effective alternative to polysomnography (PSG) for diagnosis and treatment election in patients with high clinical probability of obstructive sleep apnea (OSA), but there is conflicting evidence on its use for a wider spectrum of patients. OBJECTIVES: To determine the efficacy and cost of OSA management (diagnosis and therapeutic decision making) using (1) PSG for all patients (PSG arm); (2) HRP for all patients (HRP arm); and (3) HRP for a subsample of patients with high clinical probability of being treated with continuous positive airway pressure (CPAP) and PSG for the remainder (elective HRP arm). METHODS: Multicentric study of 366 patients with intermediate-high clinical probability of OSA, randomly subjected to HRP and PSG. We explored the diagnostic and therapeutic decision agreements between the PSG and both HRP arms for several HRP cutoff points and calculated costs for equal diagnostic and/or therapeutic decision efficacy. RESULTS: For equal diagnostic and therapeutic decision efficacy, PSG arm costs were 18% higher than HRP arm costs and 20% higher than elective HRP arm costs. HRP arm costs tended to be lower than elective HRP arm costs, and both tended to be lower than PSG arm costs if patient costs were omitted. CONCLUSION: Home respiratory polygraphy is a less costly alternative than polysomnography for the diagnosis and therapeutic decision making for patients with suspected obstructive sleep apnea. We found no advantage in cost terms, however, in using home respiratory polygraphy for all patients or home respiratory polygraphy for the most symptomatic patients and polysomnography for the rest.
Entities:
Keywords:
Cost efficacy; home respiratory polygraphy; portable monitor; sleep apnea
Authors: O Parra; N García-Esclasans; J M Montserrat; L García Eroles; J Ruíz; J A López; J M Guerra; J J Sopeña Journal: Eur Respir J Date: 1997-08 Impact factor: 16.671
Authors: W Ward Flemons; Michael R Littner; James A Rowley; Peter Gay; W McDowell Anderson; David W Hudgel; R Douglas McEvoy; Daniel I Loube Journal: Chest Date: 2003-10 Impact factor: 9.410
Authors: Juan F Masa; Jaime Corral; Ricardo Pereira; Joaquin Duran-Cantolla; Marta Cabello; Luis Hernández-Blasco; Carmen Monasterio; Alberto Alonso-Fernandez; Eusebi Chiner; Francisco-José Vázquez-Polo; Jose M Montserrat Journal: Eur Respir J Date: 2012-08-09 Impact factor: 16.671
Authors: R Ferber; R Millman; M Coppola; J Fleetham; C F Murray; C Iber; W V McCall; G Nino-Murcia; M Pressman; M Sanders Journal: Sleep Date: 1994-06 Impact factor: 5.849
Authors: E Ballester; J R Badia; L Hernández; E Carrasco; J de Pablo; C Fornas; R Rodriguez-Roisin; J M Montserrat Journal: Am J Respir Crit Care Med Date: 1999-02 Impact factor: 21.405
Authors: Michelle R Zeidler; Vicente Santiago; Joseph M Dzierzewski; Michael N Mitchell; Silverio Santiago; Jennifer L Martin Journal: J Clin Sleep Med Date: 2015-11-15 Impact factor: 4.062
Authors: Sachin R Pendharkar; Marcus Povitz; Nick Bansback; Charles F P George; Debra Morrison; Najib T Ayas Journal: CMAJ Date: 2017-12-11 Impact factor: 8.262
Authors: Vishesh K Kapur; Dennis H Auckley; Susmita Chowdhuri; David C Kuhlmann; Reena Mehra; Kannan Ramar; Christopher G Harrod Journal: J Clin Sleep Med Date: 2017-03-15 Impact factor: 4.062
Authors: Esther Oceja; Paula Rodríguez; María José Jurado; Maria Luz Alonso; Genoveva Del Río; María Ángeles Villar; Olga Mediano; Marian Martínez; Santiago Juarros; Milagros Merino; Jaime Corral; Carmen Luna; Leila Kheirandish-Gozal; David Gozal; Joaquín Durán-Cantolla Journal: Methods Protoc Date: 2021-01-19